These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2670361)

  • 1. Receptor alkylating agents: novel tools for the study of receptor function in the central nervous system of the rat.
    Crocker AD; Cameron DL
    Clin Exp Pharmacol Physiol; 1989 Jun; 16(6):545-8. PubMed ID: 2670361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Levant B
    Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of 5-HT 1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Bolaños FJ; Schechter LE; Laporte AM; Hamon M; Gozlan H
    Proc West Pharmacol Soc; 1991; 34():387-93. PubMed ID: 1838607
    [No Abstract]   [Full Text] [Related]  

  • 5. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain.
    Gozlan H; Laporte AM; Thibault S; Schechter LE; Bolaños F; Hamon M
    Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo.
    Sastre-Coll A; Esteban S; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jul; 360(1):50-62. PubMed ID: 10463334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alkylating agents on dopamine D(3) receptors in rat brain: selective protection by dopamine.
    Zhang K; Weiss NT; Tarazi FI; Kula NS; Baldessarini RJ
    Brain Res; 1999 Nov; 847(1):32-7. PubMed ID: 10564733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
    Giorgi O; Biggio G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of catecholamine release by alpha 2-adrenoceptors and I1-imidazoline receptors in rat brain.
    Meana JJ; Herrera-Marschitz M; Goiny M; Silveira R
    Brain Res; 1997 Jan; 744(2):216-26. PubMed ID: 9027381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible blockade of high-affinity choline uptake in rat brain by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Vickroy TW; Malphurs WL
    Biochem Pharmacol; 1994 Sep; 48(6):1281-7. PubMed ID: 7945422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW; Creese I
    Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
    Ekman A; Eriksson E
    Life Sci; 1991; 48(4):321-31. PubMed ID: 1824955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
    Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF
    Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkylation of rat dopamine transporters and blockade of dopamine uptake by EEDQ.
    Tarazi FI; Kula NS; Zhang K; Baldessarini RJ
    Neuropharmacology; 2000 Aug; 39(11):2133-8. PubMed ID: 10963756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
    Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local injection of alkylating and nonalkylating dopamine receptor antagonists into rat basal forebrain: autoradiographic assessment of D2-like and D3 sites.
    Yeghiayan SK; Gongwer MA; Baldessarini RJ; Kula NS; Zong R; Neumeyer JL
    Brain Res; 1998 May; 792(2):324-6. PubMed ID: 9593972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL; Ong A; McGonigle P
    Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.